Sleep-related movement disorder due to a medication or substance (Q40759): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Transtorno do movimento relacionado ao sono devido a droga ou substância é caracterizado por anormalidades do movimento relacionadas ao sono que são atribuídas diretamente ao efeito de uma medicação ou substância. Muitas substâncias podem estar associadas com anormalidades do movimento que são evidentes na vigília e no sono. Considerando que a anormalidade do movimento é uma complicação esperada da substância(s) envolvida(s) (p. ex., discinesia tardia ou acatisia associadas ao uso de neurolépticos), este diagnóstico somente deve ser determinado se os aspectos relacionados ao sono da anormalidade do movimento ou suas sequelas são o foco de atenção clínica independente.
@@ description / en / description / en @@
+Sleep-related movement disorder due to a medication or substance is characterised by sleep-related movement abnormalities that are directly attributable to the effect of a medication or substance. Many substances may be associated with movement abnormalities that are evident in wake and sleep. To the extent that the movement abnormality is an expected complication of the substance(s) involved (e.g., tardive dyskinesia or akathisia associated with neuroleptic usage), this diagnosis should only be assigned if the sleep-related aspects of the movement abnormality or its sequelae are the focus of independent clinical attention.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/158240175
@@ Property / Canonical URI: https://id.who.int/icd/entity/158240175 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:7A88
@@ Property / CURIE: CID11:7A88 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-7A88
@@ Property / Canary Token: dki-india-7A88 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F51.9
@@ Property / Linked ICD 10: F51.9 / rank @@
+Normal rank

Latest revision as of 06:42, 13 August 2026

Sleep-related movement disorder due to a medication or substance is characterised by sleep-related movement abnormalities that are directly attributable to the effect of a medication or substance. Many substances may be associated with movement abnormalities that are evident in wake and sleep. To the extent that the movement abnormality is an expected complication of the substance(s) involved (e.g., tardive dyskinesia or akathisia associated with neuroleptic usage), this diagnosis should only be assigned if the sleep-related aspects of the movement abnormality or its sequelae are the focus of independent clinical attention.

Language	Label	Description	Also known as
default for all languages	7A88
English	Sleep-related movement disorder due to a medication or substance	Sleep-related movement disorder due to a medication or substance is characterised by sleep-related movement abnormalities that are directly attributable to the effect of a medication or substance. Many substances may be associated with movement abnormalities that are evident in wake and sleep. To the extent that the movement abnormality is an expected complication of the substance(s) involved (e.g., tardive dyskinesia or akathisia associated with neuroleptic usage), this diagnosis should only be assigned if the sleep-related aspects of the movement abnormality or its sequelae are the focus of independent clinical attention.